Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo

Cancer Letters

Volumn 261, Issue 1, 2008, Pages 74-83

  Pathak, Sanjeev ^a,b   Singh, Rajinder ^a   Verschoyle, Richard D ^a   Greaves, Peter ^a   Farmer, Peter B ^a   Steward, William P ^a   Mellon, J Kilian ^b   Gescher, Andreas J ^a   Sharma, Ricky A ^a,c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Carcinogenesis; DNA damage; Flutamide; Testosterone

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANDROGEN; BIOLOGICAL MARKER; DNA; FLUTAMIDE; REACTIVE OXYGEN METABOLITE; TESTOSTERONE;

ANIMAL CELL; ARTICLE; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; DNA DAMAGE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; TANDEM MASS SPECTROMETRY;

ANDROGENS; ANIMALS; CELL LINE, TUMOR; DIHYDROTESTOSTERONE; DNA ADDUCTS; DNA DAMAGE; FLUTAMIDE; HUMANS; MALE; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 38949156821     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.11.015     Document Type: Article

References (40)

1. Hayat M.J., Howlader N., Reichman M.E., and Edwards B.K. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12 (2007) 20-37
2. Roy S.D., Philip J., and Javle P. Trends in prostate cancer incidence and survival in various socioeconomic classes: a population-based study. Int. J. Urol. 12 (2005) 644-653
3. Pathak S.K., Sharma R.A., Steward W.P., et al. Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies. Eur. J. Cancer 41 (2005) 61-70
4. Olinski R., Gackowski D., Rozalski D., et al. Oxidative DNA damage in cancer patients: a cause or a consequence of the disease development?. Mutat. Res. 531 (2003) 177-190
5. Ghosh R., and Mitchell D.L. Effect of oxidative DNA damage in promoter elements on transcription factor binding. Nucleic Acids Res. 27 (1999) 3213-3218
6. Hailer-Morrison M.K., Kotler J.M., Martin B.D., and Sugden K.D. Oxidized guanine lesions as modulators of gene transcription Altered p50 binding affinity and repair shielding by 7,8-dihydro-8-oxo-2′-deoxyguanosine lesions in the NF-kappaB promoter element. Biochemistry 42 (2003) 9761-9770
7. Nakayama M., Bennett C.J., Hicks J.L., et al. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am. J. Pathol. 163 (2003) 923-933
8. Dedon P.C., Plastaras J.P., Rouzer C.A., and Marnett L.J. Indirect mutagenesis by oxidative DNA damage: formation of the pyrimidopurinone adduct of deoxyguanosine by base propenal. Proc. Natl. Acad. Sci. USA 95 (1998) 11113-11116
9. Kadlubar F.F., Anderson K.E., Haussermann S., et al. Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutat. Res. 405 (1998) 125-133
10. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 21 (2000) 361-370
11. Ross R.K., Bernstein L., Lobo R.A., et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339 (1992) 887-889
12. Pienta K.J., and Esper P.S. Risk factors for prostate cancer. Ann. Intern. Med. 118 (1993) 793-803
13. Huggins C., Stevens R., and Hodges C. Studies on prostate cancer. The effects of castration on advanced carcinoma of the prostate gland. Arch. Surg. 43 (1941) 209-223
14. Ripple M.O., Henry W.F., Rago R.P., and Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J. Natl. Cancer Inst. 89 (1997) 40-48
15. Miyake H., Hara I., Kamidono S., and Eto H. Oxidative DNA damage in patients with prostate cancer and its response to treatment. J. Urol. 171 (2004) 1533-1536
16. Doudican N.A., Song B.W., Shadel G.S., and Doetsch P.W. Oxidative DNA damage causes mitochondrial genomic instability in Saccharomyces cerevisiae. Mol. Cell. Biol. 25 (2005) 5196-5204
17. Cheng L., Bostwick D.G., Li G., et al. Allelic imbalance in the clonal evolution of prostate carcinoma. Cancer 85 (1999) 2017-2022
18. Raivio T., Toppari J., Kaleva M., et al. Serum androgen bioactivity in cryptorchid and noncryptorchid boys during the postnatal reproductive hormone surge. J. Clin. Endocrinol. Metab. 88 (2003) 2597-2599
19. Sun X.Y., Donald S.P., and Phang J.M. Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. Carcinogenesis 22 (2001) 1775-1780
20. Tong M., and Tai H.H. Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells. Biochem. Biophys. Res. Commun. 276 (2000) 77-81
21. Lim D.J., Liu X.L., Sutkowski D.M., et al. Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice. Prostate 22 (1993) 109-118
22. Foster P.M., and Harris M.W. Changes in androgen-mediated reproductive development in male rat offspring following exposure to a single oral dose of flutamide at different gestational ages. Toxicol. Sci. 85 (2005) 1024-1032
23. Luo S., Martel C., Chen C., et al. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity. Urology 50 (1997) 913-919
24. Leuratti C., Singh R., Lagneau C., et al. Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay. Carcinogenesis 19 (1998) 1919-1924
25. Singh R., Leuratti C., Josyula S., et al. Lobe-specific increases in malondialdehyde DNA adduct formation in the livers of mice following infection with Helicobacter hepaticus. Carcinogenesis 22 (2001) 1281-1287
26. Singh R., McEwan M., Lamb J.H., et al. An improved liquid chromatography-mass spectrometry/mass spectrometry method for the determination of 8-hydroxy-2′-deoxyguanosine in DNA samples using immunoaffinity column purification. Rapid Commun. Mass Spectrom. 17 (2003) 126-134
27. Wang H., Kozekov I.D., Kozekova A., et al. Site-specific synthesis of oligonucleotides containing malondialdehyde adducts of deoxyguanosine and deoxyadenosine via a postsynthetic modification strategy. Chem. Res. Toxicol. 19 (2006) 1467-1474
28. Everett S.M., Singh R., Leuratti C., et al. Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pylori. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 369-376
29. Jeong Y.C., Nakamura J., Upton P.B., and Swenberg J.A. Pyrimido[1,2-a]-purin-10(3H)-one, M1G, is less prone to artifact than base oxidation. Nucleic Acids Res. 33 (2005) 6426-6434
30. D.J. Brambilla, A.B. O'Donnell, A.M. Matsumoto, J.B. McKinlay, Intraindividual variation in levels of serum testosterone and other reproductive adrenal hormones in men, Clin. Endocrinol., in press.
31. Griffin J.E., and Wilson J.D. Disorders of the male reproductive tract. In: Larson P.R., Kronenberg H.M., Melmed S., and Polonsky K.S. (Eds). William's Textbook of Endocrinology. tenth ed. (2002), WB Saunders, Philadelphia (pp. 709-770)
32. Manzoros C.S., Georgiadis E.I., and Trichopoulos D. Contribution of dihydrotestosterone to male sexual behaviour. Br.Med.J 310 (1995) 1289-1291
33. Pinthus J.H., Bryskin I., Trachtenberg J., Lu J.P., Singh G., Fridman E., and Wilson B.C. Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. Neoplasia 9 (2007) 68-80
34. Tam N.N.C., Gao Y., Leung Y.K., and Ho S.M. Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am. J. Pathol. 163 (2003) 2513-2522
35. Giovannini C., Chieco P., Bertaccini A., et al. Checkpoint effectors CDKN1A and Gadd45 correlate with oxidative DNA damage in human prostate carcinoma. Anticancer Res. 24 (2004) 3955-3960
36. Bartkova J., Rezaei N., Liontos M., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 (2006) 633-637
37. Otteneder M.B., Knutson C.G., Daniels J.S., et al. In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M(1)dG. Proc. Natl. Acad. Sci. USA 103 (2006) 6665-6669
38. Hu C.W., Wu M.T., Chao M.R., et al. Comparison of analyses of urinary 8-hydroxy-2′-deoxyguanosine by isotope-dilution liquid chromatography with electrospray tandem mass spectrometry and by enzyme-linked immunosorbent assay. Rapid. Commun. Mass Spectrom. 18 (2004) 505-510
39. Chen L., Stacewicz-Sapuntzakis M., Duncan C., et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J. Natl. Cancer Inst. 93 (2001) 1872-1879
40. Thompson I.M., Goodman P.J., Tangen C.M., et al. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 349 (2003) 215-224